arrow
Back
Y

Yishai Ofran

Shaare Zedek Medical Center

31H-index
194Paper Count
3.8KCitation Count
Published Papers 62
Publication Date
MRD conversion during oral azacitidine maintenance correlates with outcomes in predominantly favorable-risk AML
err2026-05-09
err0
errOAAI
errNoa Hurvitz; Irina Amitai; Ilana Levy; Ariella Tvito; Yishai Ofran; Tzvika Porges; Ofir Wolach; Adi Sherban; Noa Gross Even-Zohar; Vladimir Vainstein; Arnon Haran; Shlomzion Aumann; Robert Mikhelashvili; Avraham Frisch; Boaz Nachmias
errShare
errSave
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS
err2025-05-09
err0
errOAAI
errAmy E. DeZern; Sylvain Thepot; Stephane de Botton; Andrea Patriarca; Dries Deeren; Jose-Miguel Torregrossa-Diaz; Giovanni Marconi; Teresa Bernal; Juan Bergua Burgues; Blanca Xicoy; Anna Jonášová; Amer M. Zeidan; Sophie Dimicoli-Salazar; Célestine Simand; David Valcarcel; Maria Diez Campelo; Wanxing Chai-Ho; Lalit Saini; Alice Garnier; Klaus Geissler; Yishai Ofran; Zsolt Nagy; Pramila Krishnamurthy; Michael Lübbert; Grzegorz Basak; Hetty E. Carraway; David A. Sallman; Uma Borate; Valeria Santini; Victoria Campbell; Pierre Fenaux; Thorsten Braun; Francesco Lanza; Jan Maciej Zaucha; David A. Roth; Sofia Paul; Pourab Roy; Michael J. Kelly; Angela Volkert; Jaime Chisholm; Tanya Abdul Malak; Virginia M. Klimek; Thomas Cluzeau
errShare
errSave
Mitochondrial Augmentation of Hematopoietic Stem and Progenitor Cells As a New Therapeutic Approach for Myelodysplasia
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errFujino, Takeshi; Avni, Noa; Kutner, Neta; Khoury, Hanan; Pozner, Gat; Sabath, Niv; Castro, Cynthia; Fox, Nina; Lewis, Alexander M.; Tittley, Steven; Ziv, Oren; Ofran, Yishai; Napso, Tina; Ohana, Natalie Yivgi; Sher, Noa; Abdel-Wahab, Omar
errShare
errSave
Determination of the phase 2 dose of AU-007, an AI-designed human monoclonal antibody that redirects IL-2 to T-effector cells
err2024-10-01
err0
PREAI
errWyant, T.; McKean, M.; Rasco, D.; Haydon, A. M.; Powderly, J. D.; Weickhardt, A. J.; Ahern, E. S.; De Souza, P.; Ganju, V.; Hu-Lieskovan, S.; Kichenadasse, G.; Tang, J.; Richards, L.; Knickerbocker, A.; Amit, I.; Ofran, Y.; Vasselli, J.
errShare
errSave
A NOVEL THERAPEUTICALLY ACTIVE ANTITNFR2 AGONISTIC ANTIBODY PROMOTES TREG PROLIFERATION AND INDUCTION OFTREG FUNCTIONAL MARKERS
err2024-06-01
err1
PREAI
errMiyazaki, T.; Maiti, M.; Amit, I.; Hamel, D.; Wu, Q.; Pena, R.; Brendza, K.; Chang, T.; Guo, V.; Kivimae, S.; Ofran, Y.; Zalevsky, J.
errShare
errSave
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study
err2023-11-01
err2
PREAI
errPabst, Thomas; Papayannidis, Cristina; Demirkan, Fatih; Doronin, Vadim; Fogliatto, Laura M.; Guttke, Christina; Gyan, Emmanuel; Hamad, Nada; Herrera, Pilar; Hultberg, Anna; Jacobs, Julie; Johnson, Amy J.; Langlois, Angelique; Ma, Xuewen; Martinelli, Giovanni; Arnan, Montserrat; Mueller, Rouven; Nottage, Kerri; Ofran, Yishai; Ozcan, Muhit; Samoilova, Olga; Tolbert, Jaszianne A.; Trudel, Geralyn C.; Xiu, Liang; Vey, Norbert; Wei, Andrew
errShare
errSave
Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
err2023-06-11
err10
errOAAI
errWyrobnik, Iris; Steinberg, Miryam; Gelfand, Anat; Rosenblum, Ronen; Mutlak, Yara Eid; Sulimani, Liron; Procaccia, Shiri; Ofran, Yishai; Novak-Kotzer, Hila; Meiri, David
errShare
errSave
Antitumoral effects of cannabis in Notch1-mutated T-cell acute lymphoblastic leukemia
err2023-04-21
err1
errOAAI
errBesser, Elazar; Gelfand, Anat; Lewitus, Gil Moshe; Novak-Kotzer, Hila; Procaccia, Shiri; Berman, Paula; Louria-Hayon, Igal; Shreiber-Livne, Inbar; Ofran, Yishai; Meiri, David
errShare
errSave
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study
err2022-09-16
err6
errOAAI
errJonas, Brian A.; DiNardo, Courtney; Fracchiolla, Nicola; Pristupa, Alexander; Ishizawa, Kenichi; Jin, Jie; Konopleva, Marina; Ofran, Yishai; Montesinos, Pau; Kovacsovics, Tibor; Jang, Jun-Ho; Kantarjian, Hagop; Duan, Yinghui; Potluri, Jalaja; Werner, Michael; Pratz, Keith W.
errShare
errSave
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis (Jun, 10.1007/s00277-022-04895-8, 2022)
err2022-07-23
err0
errOAAI
errShimony, Shai; Canaani, Jonathan; Kugler, Eitan; Nachmias, Boaz; Ram, Ron; Henig, Israel; Frisch, Avraham; Ganzel, Chezi; Vainstein, Vladimir; Moshe, Yakir; Aumann, Shlomzion; Yeshurun, Moshe; Ofran, Yishai; Raanani, Pia; Wolach, Ofir
errShare
errSave
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis
err2022-06-24
err16
PREAI
errShimony, Shai; Canaani, Jonathan; Kugler, Eitan; Nachmias, Boaz; Ram, Ron; Frisch, Avraham; Ganzel, Chezi; Vainstein, Vladimir; Moshe, Yakir; Aumann, Shlomzion; Yeshurun, Moshe; Ofran, Yishai; Raanani, Pia; Wolach, Ofir
errShare
errSave
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
err2022-06-23
err20
PREAI
errWolach, Ofir; Frisch, Avraham; Shargian, Liat; Yeshurun, Moshe; Apel, Arie; Vainstein, Vladimir; Moshe, Yakir; Shimony, Shai; Amit, Odelia; Bar-On, Yael; Ofran, Yishai; Raanani, Pia; Nachmias, Boaz; Ram, Ron
errShare
errSave
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
err2022-06-10
err6
errOAAI
errJonas, Brian A.; Wei, Andrew H.; Recher, Christian; DiNardo, Courtney D.; Jang, Jun-Ho; Pratz, Keith; Panayiotidis, Panayiotis; Montesinos, Pau; Yeh, Su-Peng; Ivanov, Vladimir; Fiedler, Walter; Yamauchi, Takahiro; Duan, Yinghui; Mendes, Wellington; Potluri, Jalaja; Tews, Bjorn; Ofran, Yishai
errShare
errSave
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?
errLEUKEMIA
IF13.4
err2022-04-22
err2
errOAAI
errOfran, Yishai; Rowe, Jacob M.
errShare
errSave
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
err2022-04-20
err18
errOAAI
errPratz, Keith W.; Panayiotidis, Panayiotis; Recher, Christian; Wei, Xudong; Jonas, Brian A.; Montesinos, Pau; Ivanov, Vladimir; Schuh, Andre C.; DiNardo, Courtney D.; Novak, Jan; Pejsa, Vlatko; Stevens, Don; Yeh, Su-Peng; Kim, Inho; Turgut, Mehmet; Fracchiolla, Nicola; Yamamoto, Kazuhito; Ofran, Yishai; Wei, Andrew H.; Bui, Cat N.; Benjamin, Katy; Kamalakar, Rajesh; Potluri, Jalaja; Mendes, Wellington; Devine, Jacob; Fiedler, Walter
errShare
errSave